WHO clears Bavarian Nordic's vaccine as first shot against mpox

The World Health Organization has approved Bavarian Nordic's mpox vaccine, the first to be cleared for use in African countries affected by the outbreak. This pre-qualification allows developing nations to access the vaccine, ensuring its safety and efficacy. The Democratic Republic of Congo has been severely impacted, with 37,500 infections and 1,451 deaths reported.